Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Palmieri

Showing results (311-320 of 323) with videos related to

Pageof 33
Sort By:
Bioorganic & Medicinal Chemistry|February 16, 2010
Design, synthesis, and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugsGianfabio Giorgioni, Francesco Claudi, Sabrina Ruggieri, et al.
Environmental Pollution (Barking, Essex : 1987)|April 20, 2004
Monitoring of heavy metal deposition in Northern Italy by moss analysisR Gerdol, L Bragazza, R Marchesini, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2019
Clinical evaluation of TRCReady M.TB for rapid automated detection of <i>M. tuberculosis</i> complex in respiratory samplesA Mazzarelli, A Cannas, C Venditti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2018
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) TrialW W Tan, D W Hillman, M Salim, et al.
Journal of Inherited Metabolic Disease|August 1, 1998
Carnitine-acylcarnitine carrier deficiency: identification of the molecular defect in a patientM Huizing, U Wendel, W Ruitenbeek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2009
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) TrialW W Tan, D W Hillman, M Salim, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 12, 2021
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide studyN Riccardi, L Saderi, E Borroni, et al.
Journal of Biological Regulators and Homeostatic Agents|January 13, 2016
Behaviour of dental pulp stem cells on different types of innovative mesoporous and nanoporous silicon scaffolds with different functionalizations of the surfacesM Marrelli, G Falisi, A Apicella, et al.
Le Infezioni in Medicina|August 27, 2004
[Guidelines for the management of HCV infection in HIV-infected patients. Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani]G Antonucci, A Antinori, E Boumis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 3, 2021
TB management in the European Union/European Economic Area: a multi-centre surveyG Sotgiu, S Rosales-Klintz, R Centis, et al.
Pageof 33

Showing results (311-320 of 323) with videos related to

Sort By:
Pageof 33
Bioorganic & Medicinal Chemistry|February 16, 2010
Design, synthesis, and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugsGianfabio Giorgioni, Francesco Claudi, Sabrina Ruggieri, et al.
Environmental Pollution (Barking, Essex : 1987)|April 20, 2004
Monitoring of heavy metal deposition in Northern Italy by moss analysisR Gerdol, L Bragazza, R Marchesini, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2019
Clinical evaluation of TRCReady M.TB for rapid automated detection of <i>M. tuberculosis</i> complex in respiratory samplesA Mazzarelli, A Cannas, C Venditti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2018
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) TrialW W Tan, D W Hillman, M Salim, et al.
Journal of Inherited Metabolic Disease|August 1, 1998
Carnitine-acylcarnitine carrier deficiency: identification of the molecular defect in a patientM Huizing, U Wendel, W Ruitenbeek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2009
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) TrialW W Tan, D W Hillman, M Salim, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 12, 2021
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide studyN Riccardi, L Saderi, E Borroni, et al.
Journal of Biological Regulators and Homeostatic Agents|January 13, 2016
Behaviour of dental pulp stem cells on different types of innovative mesoporous and nanoporous silicon scaffolds with different functionalizations of the surfacesM Marrelli, G Falisi, A Apicella, et al.
Le Infezioni in Medicina|August 27, 2004
[Guidelines for the management of HCV infection in HIV-infected patients. Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani]G Antonucci, A Antinori, E Boumis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 3, 2021
TB management in the European Union/European Economic Area: a multi-centre surveyG Sotgiu, S Rosales-Klintz, R Centis, et al.
Pageof 33